Know Cancer

or
forgot password
  • cancer clinical trials in new brunswick, NJ

  • Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Kidney Cancer
    A Pilot Trial to Assess the Effects of Green Tea in the Prevention of Therapy-Induced Mucositis
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Mucositis
    Dextromethorphan in Treating Patients With Fatigue Caused by Cancer
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Fatigue, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    A Pilot Study of Dextromethorphan for the Prevention and Treatment of Methotrexate Neurotoxicity
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Neurotoxicity Syndromes
    A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia
    The Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Oral Leukoplakia
    Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Osteoporosis, Prostate Cancer
    Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer
    Cancer Institute of New Jersey

    Trial Locations
    Cancer Institute of New Jersey
    Saint Peter's University Hospital
    Prostate Cancer
    Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer
    Cancer Institute of New Jersey

    Trial Locations
    Cancer Institute of New Jersey
    Saint Peter's University Hospital
    Prostate Cancer
    Etoposide and Cyclophosphamide in Treating Patients With Stage D0 Prostate Cancer
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    Prostate Cancer
    Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Cancer, Breakthrough Pain
    Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Pain, Cancer, Sickle Cell Anemia, Severe Burns
    First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients
    The Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Colorectal Cancer
    Transdermal Estradiol in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy and Chemotherapy
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    Prostate Cancer
    A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease
    The Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Hodgkin's Disease
    MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma
    The Cancer Institute of New Jersey - Robert Wood Johnson Unv. Hosp.
    New Brunswick, New Jersey 08901
    Lymphoma, Large-Cell
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
    UMDNJ - Robert Wood Johnson University Hospital
    New Brunswick, New Jersey 08903
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Breast Cancer
    Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Neuroblastoma
    Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
    The Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters
    UMDNJ-Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Thrombosis, Venous Thrombosis, Catheter Occlusion
    Gemcitabine and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic Non-Small Cell Lung Cancer
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    Lung Cancer
    Study of XL820 Given Orally Daily to Subjects With Solid Tumors
    The Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Cancer
    Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal Cancer
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Colorectal Cancer
    A Study of ATN-224 and Bortezomib in Patients With Multiple Myeloma
    The Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Multiple Myeloma
    High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Sarcoma
    Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Carcinoma, Renal Cell, Melanoma
    Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease
    Institute for Genetics Medicine Saint Peter's University Hospital
    New Brunswick, New Jersey 08903
    Gaucher Disease, Type 1, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease, Gaucher Disease, Non-Neuronopathic Form
    Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Leukemia
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    UMDNJ - Robert Wood Johnson University Hospital
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    A Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC)
    The Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Non Small Cell Lung Cancer
    Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Sarcoma
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    Leukemia
    A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancer
    The Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Prostate Cancer
    Phase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
    The Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Locally Advanced or Metastatic Breast Cancer
    Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia
    UMDNJ - Robert Wood Johnson University Hospital
    New Brunswick, New Jersey 08903
    Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myelomonocytic Leukemia (M4), Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia
    R-(-)-Gossypol and Androgen Ablation Therapy in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Adenocarcinoma of the Prostate, Stage IV Prostate Cancer
    Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Breast Cancer, Colorectal Cancer, Head and Neck Cancer, Lung Cancer, Melanoma (Skin), Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Melanoma (Skin)
    Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Lung Cancer, Non Small Cell Lung Cancer
    Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Myelodysplastic Syndrome (MDS)
    Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Lung Cancer
    Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Sarcoma
    Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Breast Cancer
    Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Breast Cancer
    Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Lung Cancer, Malnutrition, Pancreatic Cancer, Prostate Cancer, Weight Changes
    Internet Use Among Women With Recurrent Metastatic Breast Cancer
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Breast Cancer
    Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders, Depression, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Psychosocial Effects of Cancer and Its Treatment, Unspecified Adult Solid Tumor, Protocol Specific
    Combination Medications vs. Patch Alone for Medically-Ill Smokers
    Umdnj-Rwjms
    New Brunswick, New Jersey 08903
    Smoking Cessation
    Clinical Study of Plitidepsin (Aplidin®) in Combination With Cytarabine in Patients With Relapsed/Refractory Leukemia
    The Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Relapsed/Refractory Leukemia
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
    University of Medicine and Dentistry of New Jersey-NJMS
    New Brunswick, New Jersey 08903
    Crohn's Disease
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
    University of Medicine and Dentistry of New Jersey-NJMS
    New Brunswick, New Jersey 08903
    Ulcerative Colitis